Scientific instruments manufacturer Formulaction has been acquired by Microtrac MRB, a Verder Group company
Microtrac MRB, the particle characterization segment of Verder Group, has acquired Formulaction, which will be integrated into the group’s scientific division.
Founded in 1994 by Gérard Meunier, Formulaction is a manufacturer of cutting-edge instrumentation used in research and development for the characterization of physical stability, particle size, phase transitions and rheological properties of liquid dispersions. Formulaction is the inventor of Turbiscan, the world reference in stability analysis. The company employs 36 people and is headquartered in Toulouse, France, supported by two subsidiaries in Columbus, Ohio, in the USA and Aichach, Germany.
Microtrac MRB is a subsidiary of Verder Group. A leading manufacturer of particle characterization instruments and technologies, Microtrac MRB’s products are used for measuring and analyzing particle size, shape, surface area and other properties in various industries, including pharmaceuticals, chemicals, minerals and materials research.
Verder Group is a global industrial company that specializes in manufacturing and distributing high-quality equipment and solutions for various industries, including laboratory, process and fluid handling. The group offers a wide range of products, such as pumps, mixers, samplers and analytical instruments.
After 25 years of development, Formulaction’s founder Gérard Meunier started to transfer responsibilities to key managers three years ago, anticipating the transaction for the group. After a competitive process involving strategic acquirors from all over the world, Verder Group was chosen as the best strategic fit to work alongside the company’s management. Verder Group has acquired 100% of shares.
Oaklins’ team in France served as the exclusive financial advisor to Formulaction’s shareholders throughout the sale process. The team approached several acquirors worldwide and negotiated the most attractive deal for the sellers.
Gérard Meunier
Founder, Formulaction
Contacter l'équipe de la transaction
Transactions connexes
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
En apprendre plusMark Climate Technology has acquired Heber GmbH
Heber GmbH has been acquired by Mark Climate Technology, a specialist in climate control systems and a portfolio company of Bolster Investment Partners. This partnership strengthens the positions of both companies in the global market for innovative and sustainable climate solutions, as well as creating unique synergies. Mark Climate's expertise in standardized, scalable solutions is enhanced by Heber's emphasis on customer-specific customization.
En apprendre plusVivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
En apprendre plus